The general public is losing confidence in vaccination effectiveness. Vaccines are known to be one of the most effective health care interventions for disease prevention. The challenges of vaccine development are not limited to identification of suitable antigens, adjuvants and delivery methods, but include aspects related to regulatory, technical and manufacturing hurdles in translating a vaccine candidate to the clinic.Our team Vaccine subject matter experts can assist address the challenges associated with vaccine development. We are interested in licensing in technology platforms for vaccine development. We have several vaccines of interest for the US market.Upon successful proof-of-concept, we shall invest under mutually beneficial licensing agreements. Please check back later for more information. If you have any questions or are interested in partnering or licensing-in your technology, do contact us as vac.bd@e2ebiosys.com |